DCF
Free cash flow, growth, discount rate, and terminal growth form an intrinsic value range.
+118%
US · US
DLR.US latest organized financial period shows revenue grew +10.04% YoY and net income grew +117% YoY. Current price is about 193 USD, while the model base case is about 88.5 USD; the current price sits +118% versus the base case. The page shows both reported and adjusted views; valuation still defaults to reported figures, while adjusted figures help isolate structured one-time-item impact. This summary is intended for public-information research and model review.
Annual financial metrics with switchable views. · Unit: USD
Price date: 2026/04/29 · Updated: 2026/04/29 15:27
Hover each model row to inspect formulas and inputs.
+118%
Free cash flow, growth, discount rate, and terminal growth form an intrinsic value range.
+118%
Uses recent net income as an owner-earnings proxy and discounts scenario growth.
+85.93%
Solves the forward FCF growth rate implied by the current price.
Current price implies roughly 10.0% annualized FCF growth.
Estimates earnings power value without assuming growth.
+1,356%
Updated: 2026/04/29 15:27
Collapsed by default. Expand to inspect structured one-time items and adjusted figures without making them the primary page focus.
A positive amountAfterTax means the item increased reported net income; a negative value means it reduced reported net income. Adjusted net income = reported net income minus total after-tax impact. Valuation defaults to reported figures; adjusted figures are shown to observe one-time-item impact.
| Period | Item | Category | After-tax impact | Confidence |
|---|---|---|---|---|
| 2025/12/31 | Asset impairment | Impairment | -62M USD | Medium |
| 2025/12/31 | Asset sale gain/loss | Asset sale gain/loss | 787M USD | Medium |
| 2024/12/31 | Asset impairment | Impairment | -302M USD | Medium |
| 2024/12/31 | Asset sale gain/loss | Asset sale gain/loss | 941M USD | Medium |
| 2023/12/31 | Asset impairment | Impairment | -281M USD | Medium |
| 2023/12/31 | Asset sale gain/loss | Asset sale gain/loss | 2B USD | Medium |
| 2022/12/31 | Asset impairment | Impairment | -5M USD | Medium |
| 2022/12/31 | Asset sale gain/loss | Asset sale gain/loss | 419M USD | Medium |
| 2021/12/31 | Asset impairment | Impairment | -14M USD | Medium |
| 2021/12/31 | Asset sale gain/loss | Asset sale gain/loss | 3B USD | Medium |
| 2020/12/31 | Asset sale gain/loss | Asset sale gain/loss | 751M USD | Medium |
| 2025/09/30 | Asset sale gain/loss | Asset sale gain/loss | 753M USD | Medium |
| 2025/06/30 | Asset sale gain/loss | Asset sale gain/loss | 737M USD | Medium |
| 2025/03/31 | Asset sale gain/loss | Asset sale gain/loss | 878K USD | Medium |
| 2024/09/30 | Asset impairment | Impairment | -266M USD | Medium |
| 2024/09/30 | Asset sale gain/loss | Asset sale gain/loss | 712M USD | Medium |
| 2024/06/30 | Asset impairment | Impairment | -532M USD | Medium |
| 2024/06/30 | Asset sale gain/loss | Asset sale gain/loss | 713M USD | Medium |
| Period | Type | Revenue | Net Income | Adjusted net income | Free Cash Flow | Diluted EPS | Adjusted EPS |
|---|---|---|---|---|---|---|---|
| 2025/12/31 | Annual | 6B USD | 1B USD | 584M USD | 2B USD | 3.58 | 1.6 |
| 2024/12/31 | Annual | 6B USD | 602M USD | -37M USD | 2B USD | 1.61 | -0.1 |
| 2023/12/31 | Annual | 5B USD | 949M USD | -905M USD | 2B USD | 3 | -2.86 |
| 2022/12/31 | Annual | 5B USD | 378M USD | -36M USD | 2B USD | 1.11 | -0.11 |
| 2021/12/31 | Annual | 4B USD | 2B USD | -2B USD | 2B USD | 5.94 | -5.38 |
Total revenue recognized in each fiscal year.
Adjusted close trend. Current price sample covers: 2025/04/16 - 2026/04/29.